文献速递肺血管病与心包/心肌炎

球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压:国际多中心前瞻性注册研究结果

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective Registry.
PubMed 文献 · J Am Coll Cardiol · 2025-01-01

国际BPA注册研究前瞻性纳入2018年3月至2020年3月间18个中心的500例慢性血栓栓塞性肺动脉高压患者,484例纳入分析。中位5次BPA后,mPAP下降15 mmHg(38%),PVR下降332 dynes/s/cm-5(57%),动脉血氧饱和度升高3.2%(中位数,P<0.001),功能分级、6分钟步行距离等均显著改善;并发症发生于11.3%的操作和33.9%的患者,多为咯血,30天内无死亡。

要点

  • BPA可显著降低mPAP和PVR并改善功能状态,30天内无死亡。
  • 并发症发生于11.3%的操作和33.9%的患者,以咯血为主。
  • 女性、欧美操作、曾用肺动脉高压药物及基线PVR较高为并发症独立预测因素。

核心结论

  • BPA可改善慢性血栓栓塞性肺动脉高压患者的临床和血流动力学参数,并发症率与既往报告一致。
  • 经验更丰富的中心更可能获得更高的PVR下降百分比。

研究设计与样本

  • 国际BPA注册研究(NCT03245268)为前瞻性、连续性、多中心注册研究,覆盖美国、欧洲和日本18个中心。
  • 2018年3月至2020年3月共纳入500例患者,随访至2022年3月,484例纳入分析集。

主要发现

  • 中位5次(Q1-Q3:3-6)BPA,中位时间4.9个月(Q1-Q3:1.7-11.0)内,mPAP中位下降15 mmHg(38%),PVR中位下降332 dynes/s/cm-5(57%),动脉血氧饱和度中位升高3.2%(P<0.001)。
  • 功能分级、6分钟步行距离、血清N末端脑钠肽前体水平及Borg呼吸困难指数均显著改善。
  • 并发症发生于11.3%的操作和33.9%的患者,多为咯血,30天内无死亡。
  • 女性、欧洲/美国操作、任何时间使用肺动脉高压药物及较高基线PVR为BPA并发症的独立预测因素。
  • 日本患者既往肺内膜剥脱术较少、老年女性较多,且操作细节存在区域差异。

临床怎么用

  • 对于不适合肺内膜剥脱术的慢性血栓栓塞性肺动脉高压患者,BPA是可考虑的介入治疗选择。
  • 应关注女性、欧美操作、使用肺动脉高压药物及高基线PVR患者的并发症风险。
  • 中心经验可能与PVR下降幅度相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic thromboembolic pulmonary hypertension results from mechanical obstruction of major pulmonary artery lumina with fibrotic tissue. Main treatment has been pulmonary endarterectomy, a complex surgical procedure removing vascular obstruction. However, at least 40% of patients are not candidates for pulmonary endarterectomy because of technical inoperability, comorbidities, or limited access to surgery. Balloon pulmonary angioplasty (BPA) has emerged as an interventional treatment for these patients. OBJECTIVES: The International BPA Registry (NCT03245268) was designed to investigate BPA practice across 18 established centers in the United States, Europe, and Japan. METHODS: A total of 500 patients were prospectively and consecutively enrolled between March 2018 and March 2020, with follow-up until March 2022. Of these, 484 patients were included in the analysis set. RESULTS: Regional differences were seen in patient characteristics (fewer patients with prior pulmonary endarterectomy and more elderly women in Japan) and procedural details (less medical pretreatment, more jugular access, more segments and more occlusive lesions treated per session and patient, less conscious sedation, less contrast and less radiation, shorter intervals between BPA sessions in Japan). Female sex, procedure in Europe/United States, pulmonary hypertension medications at any time, and higher baseline pulmonary vascular resistance (PVR), calculated as transpulmonary pressure gradient divided by cardiac output, emerged as independent predictors of complications during BPA. After a median of 5 (Q1-Q3: 3-6) BPA sessions per patient within a median time of 4.9 months (Q1-Q3: 1.7-11.0 months), a 15-mm Hg (38%) decrease in mPAP, a 332 dynes/s/cm-5 (57%) decrease in PVR, and a 3.2% increase in arterial saturation (medians; P < 0.001) were observed, and there were significant improvements in functional class, 6-minute walk distance, serum levels of N-terminal probrain natriuretic peptide, and Borg dyspnea index. BPA complications occurred in 11.3% of sessions and 33.9% of patients and were mostly hemoptyses. No patient died within 30 days of BPA. CONCLUSIONS: Our data are in line with previous reports on changes of clinical and hemodynamic parameters and complication rates of BPA. Centers with more experience providing BPAs were more likely to achieve a higher percentage decrease in PVR.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Lang IM, Brenot P, Bouvaist H, et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective Registry. J Am Coll Cardiol. 2025. PMID: 40499982. doi:10.1016/j.jacc.2025.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。